Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Global Hemp Group Inc C.GHG

Alternate Symbol(s):  GBHPF

Global Hemp Group Inc. is a Canada-based company, which is focused on developing and promoting hemp-based products. The Company operates through two segments: BioPharma Division and Industrial Hemp Division. BioPharma Division has executed a Letter of Intent (LOI) with B-Organic R&D Corp. (B-Organic) to license its Bioactive Lipid Agents (BLA) technology, a patented matrix, which is able to increase the solubility and bioavailability of various poorly soluble pharma ingredients, including cannabinoids. Industrial Hemp Division is involved in the development and promotion of hemp-based products. The Company’s has acquired the perpetual license for North America (the United States, Canada and Mexico) to certain Apollon Intellectual Property and proprietary technology.


CSE:GHG - Post by User

Bullboard Posts
Comment by GGORI94on Sep 13, 2017 10:21am
90 Views
Post# 26689573

RE:RE:RE:Looking to buy

RE:RE:RE:Looking to buy

If anyone actually checked the website most of their questions would have been answered... Here I copy and pasted this from the projects page of GHGs website. This is the Cannabis opportunities that theyre exploring.

 

The demand for recreational and medicinal marijuana in Washington State and other Western States is growing year-over-year and in the short-term, and does not show any signs of slowing down. In Washington there are currently up to 650,000 recreational marijuana users in Washington State, generating approximately US$1.25 – US$1.5 Billion in annual sales. Beyond the traditional uses for cannabis, the industry has benefited greatly from innovative product development and a variety of consumables and CBD products for medical use. The continued upward trajectory of growth in the U.S. market is positively forecasted for years to come for all U.S. States and many countries.

In 2016 Frank Giese, an expert cannabis cultivator and breeder, Medical Marijuana (MMJ) contractor, and MMJ systems analyst joined the Company’s Advisory Board to assist Management in the development of genetics and cannabis related project opportunities in Washington and Oregon states.

Mr. Giese’s current cannabis breeding efforts are focused on commercially viable, rapidly maturing varieties and his continued efforts in the development of new industrial hemp cultivars. His vision for the future is to introduce modern growing techniques to industrial hemp, as has been done with cannabis.

Management continues to evaluate cannabis related project opportunities in all legal recreational and MMJ States.

Bullboard Posts